Cocoon Bioscience was founded in 2022 as a spin-off of the company Algenex, with the aim of producing biocompounds obtained through CrisBio® technology for the health and food markets, with the licence to exploit four patents related to the technology.
The company’s growth strategy is focused on strengthening its R&D activity aimed at developing new products, as well as developing new production processes to improve efficiency and reduce costs in order to improve competitiveness.
Cocoon currently has R&D facilities in Tres Cantos, Madrid. In addition, it has installed its pilot plant in the BIC, which will allow it to prepare to scale up its production to its new industrial facility located in the Bizkaia Technology Park, which will be operational in 2024 and will have a production capacity of more than 15 kilograms per year of these biocomposites.
The CrisBio® technology is based on the expression of baculovirus vectors using the chrysalis of the Trichoplusia Ni worm as a natural bioreactor to produce biocomposites, and has the potential to offer a number of important advantages compared to industrial bioreactors, as it allows for higher scalability and performance at much lower costs.
In 2021, the EMA (European Medicines Agency) validated the technology by issuing a favourable opinion for a vaccine produced with the technology, thus boosting the application of CrisBio® as an alternative to current expression technologies. CrisBio® aims to become a new paradigm in the production of biological products to meet the global demand for growth factors for the cultured meat industry, enzymes involved in the manipulation of nucleic acids for the biotechnology industry and other biocomponents.
- Website
- View web
A3Z is a company founded in 2016 by a group of senior technicians with wide experience in analytical development, quality control and quality assurance areas in the pharma industry. They provide experience as partnersof different companies for the development of […]- Website
- View web
Anbiotek Biotechnologies S.L. commercially known as Anbiolab is a company that applies innovation and development of biomolecular analysis, fundamentally last generation genetics, in sectors such as food, environment, livestock and agriculture. The main challenge of the company is to promote […]- Website
- View web
Cocoon Bioscience was founded in 2022 as a spin-off of the company Algenex, with the aim of producing biocompounds obtained through CrisBio® technology for the health and food markets, with the licence to exploit four patents related to the technology. […]- Website
- View web
Glycoscience has developed a new technological platform that represents the launch of a totally new concept in the processes of releasing compounds for topical application on human skin. Innovation based on the enzymatic modification of alcohols with biological activity, will […]- Website
- View web
HAWK Biosystems is a biotechnology start-up created in 2016, which has developed QF-Pro®, a highly sensitive and specific microscopy platform for the quantification of novel biomarkers. This platform is designed to quantify the activation states of proteins and the formation […]- Website
- View web
Innitius is a spin-off of the Andalusian Health Service and the University of Granada. The startup was created in January 2018 as a result of the collaboration agreement between both entities to carry out a series of research projects that […]- Website
- View web
Human food faces major sustainability challenges. The impact of these industries on the environment is gigantic. Innomy develops superior alternatives to animal-based foods, and does so with proprietary technologies using fungal tissue cultures. Fungi are a kingdom of organisms with […]- Insekt Label Biotech is a biotechnology company founded in March 2019 whose objective is to offer solutions and high value products based on the Tenebrio molitor insect species through biochemical and transformation technologies, aimed at specific market niches that are […]
- Website
- View web
Mikrobiomik is a biopharmaceutical company, born to research, develop and market medicines based on human microbiota, providing innovative solutions in chronic diseases, currently without cost-efficient alternatives. We want to lead the paradigm change that will involve designing therapeutic solutions based […]- Website
- View web
QUEST is a company in the biotechnology sector that designs, develops and offers the market innovative solutions in terms of products, processes and integrated systems in the field of dental implantology and oral surgery. The know-how of the company has […]- Syngoi Technologies is a new company incorporated in February 2021 and is the result of an initial seed investment by the venture capital fund dedicated to Health and Life Sciences Columbus Venture Partners (http://columbusvp.com). Syngoi is dedicated to the production […]
- Website
- View web
TAD is a biotechnology drug discovery company created in December 2015. Driven by founding partners with extensive experience in pharmaceutical multinationals, TAD aims to provide a different vision of drug discovery. This vision is based on the use of artificial […]
